Clinical Trial Update: TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing TTT alone versus TTT with Triamcinolone to decrease exudation in choroidal/uveal melanoma after proton beam therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Melanoma
• Exudative Retinal Detachment
• Uveal Melanoma

Drugs mentioned

• TTT
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Exudative Retinal Detachment, Uveal Melanoma | Phase 4 | Status: UNKNOWN